National Lipid Association (NLA) Conference Coverage 2023


Share

Program Content

Activities

  • Very-High Risk ASCVD With CAC ≥1000
    Prognostic Markers of Very-High Risk ASCVD in Persons With CAC ≥1000
    Capsule Summary
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 06, 2023

    View Activity
  • CLEAR Outcomes
    CLEAR Outcomes: Bempedoic Acid Reduces Risk of Major Cardiovascular Event vs Placebo in Statin-Intolerant Patients
    Capsule Summary
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 07, 2023

    View Activity
  • ROSE2
    ROSE2: Phase II Trial of Obicetrapib + Ezetimibe as an Adjunct to High-Intensity Statin Therapy
    Capsule Summary
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 08, 2023

    View Activity
  • NLA 2023 Key Takeaways
    Expert Analysis and Conference Coverage of NLA 2023
    Conference Coverage
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 09, 2023

    Expires: June 08, 2024

    View Activity
  • NLA Pearls 2023
    An Expert’s Guide to National Lipid Association 2023: Pearls and Takeaways
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 15, 2023

    View Activity

Faculty

cover img faculity

Payal Kohli, MD, FACC

Noninvasive and Preventive Cardiologist
Founder and Medical Director, Cherry Creek Heart
Associate Clinical Professor of Medicine, University of Colorado, Anschutz
Director of Medical Communications, Baim Institute for Clinical Research
On-Air Medical Expert, Tegna Broadcasting
Aurora, Colorado

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

This program is supported by an educational grant from Esperion Therapeutics.

Esperion Therapeutics